Takeda

AcuraStem and Takeda Partner to Revolutionize ALS Treatment
Best Stocks
Mon, 09/25/23 - 07:40 pm
Takeda
AcuraStem
ALS
AS-202
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Thu, 09/21/23 - 11:51 am
Takeda
generics
gout
Colcrys
antitrust
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Thu, 09/21/23 - 11:47 am
Roche
Takeda
patents
legal
Genentech
Baxalta
hemophilia
AbbVie in line for hefty payout after Takeda breached supply contract on Lupron
Fierce Pharma
Thu, 09/7/23 - 10:25 am
AbbVie
Takeda
legal
Lupron
Fresh off $4B deal, Nimbus gears up for ‘third chapter’ with new fundraise
BioPharma Dive
Wed, 09/6/23 - 10:08 am
Nimbus Therapeutics
Takeda
funding
cancer
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window'
Fierce Biotech
Wed, 08/9/23 - 11:56 am
Takeda
Denali Therapeutics
Alzheimer's disease
clinical trials
FDA Clears Taiho’s Lonsurf in Metastatic Colorectal Cancer Ahead of Takeda, Hutchmed
BioSpace
Thu, 08/3/23 - 10:23 am
Taiho Oncology
Lonsurf
colorectal cancer
FDA
Takeda
Hutchmed
Filings signal: Despite Covid losses, pharma earnings are promising
Clinical Trials Arena
Wed, 08/2/23 - 11:32 am
Takeda
AstraZeneca
Roche
earnings
COVID-19
Takeda reports data from Phase II narcolepsy type 1 therapy trial
Clinical Trials Arena
Thu, 07/27/23 - 10:16 am
Takeda
TAK-994
narcolepsy
clinical trials
J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next
Fierce Pharma
Mon, 07/17/23 - 07:04 pm
JNJ
Rybrevant
non-small cell lung cancer
Takeda
Tagrisso
Takeda withdraws FDA approval application for dengue vaccine
BioPharma Dive
Tue, 07/11/23 - 11:22 pm
Takeda
FDA
dengue
vaccines
Takeda adds another F-Star collab to constellation, this time for $1B in biobucks
Fierce Biotech
Wed, 07/5/23 - 07:06 pm
Takeda
F-star Therapeutics
bispecific antibodies
immuno-oncology
Takeda reports interim results from Phase III trial of cTTP therapy
Clinical Trials Arena
Mon, 06/26/23 - 09:45 am
Takeda
TAK-755
cogenital thrombocytopenic purpura
ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity
Yahoo/Benzinga
Thu, 06/22/23 - 11:21 am
ADHD
Vyvanse
drug shortages
Takeda
Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug
BioSpace
Thu, 06/8/23 - 10:13 am
Eli Lilly
Takeda
legal
Actos
bladder cancer
diabetes
racketeering
Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
Fierce Pharma
Wed, 05/31/23 - 06:59 pm
Yuhan
cancer
Boehringer Ingelheim
Takeda
HER2 inhbitor
non-small cell lung cancer
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wed, 05/31/23 - 11:15 am
layoffs
Rain Oncology
Takeda
PTC Therapeutics
Affimed
Urovant Sciences
Roche
Novavax
Gossamer Bio
Bristol Myers Squibb
ADC Therapeutics
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
FDA grants priority review for Takeda and HUTCHMED’s fruquintinib NDA
Pharmaceutical Technology
Fri, 05/26/23 - 11:31 am
Takeda
Hutchmed
FDA
fruquintinib
colorectal cancer

Pages